Natalizumab as an Efficacy Switch in Participants With Relapsing Multiple Sclerosis After Failure on Other Therapies

Research Site, Plainview

Research Site, Knoxville

Research Site, Cleveland

Research Site, Akron

Research Site, Des Moines

Research Site, St Louis

Research Site, Round Rock

Research Site, Aurora

Research Site, Fullerton

Research Site, Tacoma

Research Site, Raleigh